Clinical Trials for Refractory/recurrent Central Nervous System Lymphoma

Find clinical trials for refractory/recurrent central nervous system lymphoma. Discover research opportunities and treatment options in your area.

1 Active Trial Found

Showing 1 trial on this page

Page 1 of 1

Cord Blood-derived CAR-NK Cells Targeting CD19 for Refractory/relapsed Central Nervous System Lymphoma

NCT ID: NCT06827782

Enrolling by invitation

Phase: PHASE1 Type: interventional Locations: Hangzhou, Zhejiang, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions